Procedural performance between two cryoballoon systems for ablation of atrial fibrillation depends on pulmonary vein anatomy.

Autor:	Menger, Vincent, Frick, Michael, Sharif‐Yakan, Ahmad, Emrani, Mahdi, Zink, Matthias Daniel, Napp, Andreas, Marx, Nikolaus, Gramlich, Michael
Předmět:	ATRIAL fibrillation treatment MAGNETIC resonance angiography ECHOCARDIOGRAPHY IN vitro studies CLINICAL trials CONFIDENCE intervals COLD therapy LOG-rank test CATHETER ablation FISHER exact test MANN Whitney U Test TREATMENT effectiveness DYNAMICS DESCRIPTIVE statistics CHI-squared test KAPLAN-Meier estimator RESEARCH funding PULMONARY veins DATA analysis software LONGITUDINAL method PROPORTIONAL hazards models
Zdroj:	Journal of Arrhythmia; Jun2023, Vol. 39 Issue 3, p341-351, 11p
Abstrakt:	Background: Cryoballoon ablation is a first‐line therapy for atrial fibrillation. We compared the efficacy and safety of two ablation systems and addressed the influence of pulmonary vein (PV) anatomy on performance and outcome. Methods: We consecutively enrolled 122 patients who were planned for first‐time cryoballoon ablation. Patients were assigned 1:1 for ablation with the POLARx or the Arctic Front Advance Pro (AFAP) system and followed‐up for 12 months. Procedural parameters were recorded during the ablation. Before the procedure, a magnetic resonance angiography (MRA) of the PVs was generated and diameter, area, and shape of each PV ostium were assessed. We applied an evaluated PV anatomical scoring system on our MRA measurement data ranging from 0 (best anatomical combination) to 5. Results: Procedures performed with POLARx were associated with shorter time to balloon temperature −30°C (p <.001), lower balloon nadir temperature (p <.001), and longer thawing time till 0°C (p <.001) in all PVs, however, time to isolation was similar. We observed a decreasing performance with each increase in the score for the AFAP, whereas the POLARx performed constant regardless of the score. At 1 year, AF recurred in 14 of 44 patients treated with AFAP (31.8%) and in 10 of 45 patients treated with POLARx (22.2%) (hazard ratio, 0.61; 95% CI 0.28 to 1.37; p =.225). There was no significant correlation between PV anatomy and clinical outcome. Conclusion: We found significant differences in cooling kinetics, especially when anatomical conditions are difficult. However, both systems have a comparable outcome and safety profile. [ABSTRACT FROM AUTHOR]
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Plný text